In this issue:
Cancer in paediatric-onset IBD
TTT for ustekinumab-treated CD
Intensive drug therapy for symptomatic intestinal CD strictures
Loss of response and need for ustekinumab dose escalation in IBD
Advanced neoplasms in IBD with indefinite or low-grade dysplasia
IBD incidence in Sweden
Humoral immune response to SARS-COV-2 vaccine in IBD
Tofacitinib in UC according to prior anti-TNF failure
Neurodegenerative disease risk in IBD
Oral vs. intravenous iron for iron-deficiency anaemia in IBD
Please login below to download this issue (PDF)